V. Potters

2014 WHO Clinical Molecular and Pathological (WHO-CMP) Diagnostic Criteria for the Classification and Staging of Five Distinct JAK2, MPL and CALR Mutated Myeloproliferative Neoplasms

K. Schelfout, J. Michiels, F. Valster, 2014 .

Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients

Yonggoo Kim, Z. Berneman, Myungshin Kim, 2019, International Journal of Bone Marrow Research.

Bone Marrow Histology is a Pathognomonic Clue to Each of the JAK2 V617F , MPL,515 and Calreticulin Mutated Thrombocythemia in Myeloproliferative Neoplasms

Z. Berneman, Myungshin Kim, Y. Kim, 2018 .

Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

G. Tytgat, W. D. de Boer, V. Potters, 1994, The American journal of gastroenterology.

Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels

A. Trifa, Kim， Dong-Wook, A. Pich, 2020, International Journal of Bone Marrow Research.

Increased Erythrocyte Count on Top of Bone Marrow Histology but not Serum EPO Level or JAK2 Mutation Load Discriminates between JAK2V617F Mutated Essential Thrombocythemia and Polycythemia Vera

K. Schelfout, M. Medinger, J. Michiels, 2015 .

Extension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and Kralovics

Yonggoo Kim, Myungshin Kim, H. de Raeve, 2017, European Medical Journal.